188 related articles for article (PubMed ID: 30297863)
21. Mapping Region of Human Restriction Factor APOBEC3H Critical for Interaction with HIV-1 Vif.
Nakashima M; Tsuzuki S; Awazu H; Hamano A; Okada A; Ode H; Maejima M; Hachiya A; Yokomaku Y; Watanabe N; Akari H; Iwatani Y
J Mol Biol; 2017 Apr; 429(8):1262-1276. PubMed ID: 28336404
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity.
Li MM; Emerman M
J Virol; 2011 Aug; 85(16):8197-207. PubMed ID: 21653666
[TBL] [Abstract][Full Text] [Related]
23. Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.
Nomaguchi M; Doi N; Sakai Y; Ode H; Iwatani Y; Ueno T; Matsumoto Y; Miyazaki Y; Masuda T; Adachi A
J Virol; 2016 May; 90(9):4563-4578. PubMed ID: 26912631
[TBL] [Abstract][Full Text] [Related]
24. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
25. Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.
Zhang Z; Gu Q; de Manuel Montero M; Bravo IG; Marques-Bonet T; Häussinger D; Münk C
PLoS Pathog; 2017 Dec; 13(12):e1006746. PubMed ID: 29267382
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.
Sakurai D; Iwatani Y; Ohtani H; Naruse TK; Terunuma H; Sugiura W; Kimura A
Immunogenetics; 2015 Apr; 67(4):253-7. PubMed ID: 25721876
[TBL] [Abstract][Full Text] [Related]
27. Recurrent Loss of APOBEC3H Activity during Primate Evolution.
Garcia EI; Emerman M
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925657
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in Human APOBEC3H Differentially Regulate Ubiquitination and Antiviral Activity.
Chesarino NM; Emerman M
Viruses; 2020 Mar; 12(4):. PubMed ID: 32235597
[TBL] [Abstract][Full Text] [Related]
29. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.
Starrett GJ; Luengas EM; McCann JL; Ebrahimi D; Temiz NA; Love RP; Feng Y; Adolph MB; Chelico L; Law EK; Carpenter MA; Harris RS
Nat Commun; 2016 Sep; 7():12918. PubMed ID: 27650891
[TBL] [Abstract][Full Text] [Related]
30. Natural APOBEC3C variants can elicit differential HIV-1 restriction activity.
Anderson BD; Ikeda T; Moghadasi SA; Martin AS; Brown WL; Harris RS
Retrovirology; 2018 Dec; 15(1):78. PubMed ID: 30558640
[TBL] [Abstract][Full Text] [Related]
31. The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.
Shaban NM; Shi K; Lauer KV; Carpenter MA; Richards CM; Salamango D; Wang J; Lopresti MW; Banerjee S; Levin-Klein R; Brown WL; Aihara H; Harris RS
Mol Cell; 2018 Jan; 69(1):75-86.e9. PubMed ID: 29290613
[TBL] [Abstract][Full Text] [Related]
32. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.
Tan L; Sarkis PT; Wang T; Tian C; Yu XF
FASEB J; 2009 Jan; 23(1):279-87. PubMed ID: 18827027
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.
Jiang ZQ; Yao XR; Yu H; Lu YE; Liu BL; Liu FL; Jin YB; Zhuo M; Zheng YT; Ling F
Arch Virol; 2019 May; 164(5):1353-1360. PubMed ID: 30859472
[TBL] [Abstract][Full Text] [Related]
34. Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.
Benito JM; Hillung J; Restrepo C; Cuevas JM; León A; Ruiz-Mateos E; Palacios-Muñoz R; Górgolas M; Sanjuán R; Rallón N
Int J Med Sci; 2018; 15(2):95-100. PubMed ID: 29333092
[No Abstract] [Full Text] [Related]
35. Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H.
Ito F; Yang H; Xiao X; Li SX; Wolfe A; Zirkle B; Arutiunian V; Chen XS
Sci Rep; 2018 Feb; 8(1):3763. PubMed ID: 29491387
[TBL] [Abstract][Full Text] [Related]
36. Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Jeyaraj M; Schmidt S; Zielonka J; Perković M; Heckel JO; Cichutek K; Häussinger D; Smits SHJ; Münk C
J Virol; 2016 Nov; 90(22):10193-10208. PubMed ID: 27581978
[TBL] [Abstract][Full Text] [Related]
37. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
[TBL] [Abstract][Full Text] [Related]
38. RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids.
Feng Y; Wong L; Morse M; Rouzina I; Williams MC; Chelico L
J Mol Biol; 2018 Dec; 430(24):4891-4907. PubMed ID: 30414963
[TBL] [Abstract][Full Text] [Related]
39. ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.
Miyakawa K; Matsunaga S; Kanou K; Matsuzawa A; Morishita R; Kudoh A; Shindo K; Yokoyama M; Sato H; Kimura H; Tamura T; Yamamoto N; Ichijo H; Takaori-Kondo A; Ryo A
Nat Commun; 2015 Apr; 6():6945. PubMed ID: 25901786
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.
Reddy K; Ooms M; Letko M; Garrett N; Simon V; Ndung'u T
AIDS; 2016 Jul; 30(11):1723-9. PubMed ID: 27064995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
